Adrienne Farid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adrienne farid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adrienne Farid Today - Breaking & Trending Today

Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $14.17

Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $14.17
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Adrienne Farid , Canaccord Genuity Group , Barclays Plc , Wells Fargo Company , Citigroup Inc , Century Therapeutics Inc , Securities Exchange Commission , Century Therapeutics , Get Free Report , Genuity Group , Exchange Commission , Public Employees Retirement System , Get Free , Century Therapeutics Daily ,

Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […] ....

Adrienne Farid , Century Therapeutics Inc , Mabel Hall , Virtu Financial , Vanguard Group Inc , Century Therapeutics Company Profile , Barclays Plc , Canaccord Genuity Group , Securities Exchange Commission , Century Therapeutics , Get Free Report , Marketbeat Ratings , Genuity Group , Exchange Commission , Avidity Partners Management , Partners Management , Get Free , Century Therapeutics Daily ,

Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among […] ....

Adrienne Farid , Century Therapeutics Company Profile , Canaccord Genuity Group , Blackrock Inc , Hermes Inc , Century Therapeutics Inc , Securities Exchange Commission , Vanguard Group Inc , Century Therapeutics , Get Free Report , Marketbeat Ratings , Genuity Group , Therapeutics Stock Down , Exchange Commission , Partners Management , State Street Corp , Street Corp , Get Free , Century Therapeutics Daily , Nasdaq Ipsc ,